Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age

The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses

Novartis unveils new focused strategy

Transformation to pure-play Innovative Medicines company nears completion

Puneet Sud appointed additional director of Nectar Lifesciences

Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin

Aptar Pharma collaborates with Fluidda

The companies will leverage their respective proprietary technology platforms

Madhavbaug plans to foray in UAE, Europe & US

To set up 50 lifestyle modification centres across the UAE in the next 24 months

India achieves significant landmark in reduction of child mortality rates

The country has been witnessing a progressive reduction in IMR, U5MR and NMR

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune

KDAH receives SMART ICU certification after pandemic

Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification

Aster Pharmacy forays into Bangladesh

Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.

DME market across 7MM set to reach $11.1 billion in 2031, forecasts GlobalData